利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

4 条记录 (耗时 0.04 秒)

    Dihydroquinone and dihydronaphthridine inhibitors of JNK
    1.
    发明授权
    Dihydroquinone and dihydronaphthridine inhibitors of JNK 有权
    二氢醌和二氢萘并吡嗪类抑制剂

    公开(公告)号：US08163906B2

    公开(公告)日：2012-04-24

    申请号：US12152432

    申请日：2008-05-14

    申请人： Sarah C. Abbot ,  Geneviève N. Boice ,  Bernd Buettelmann ,  David Michael Goldstein ,  Leyi Gong ,  Joan Heather Hogg ,  Pravin Iyer ,  Kristen Lynn McCaleb ,  Yun-chou Tan

    发明人： Sarah C. Abbot ,  Geneviève N. Boice ,  Bernd Buettelmann ,  David Michael Goldstein ,  Leyi Gong ,  Joan Heather Hogg ,  Pravin Iyer ,  Kristen Lynn McCaleb ,  Yun-chou Tan

    IPC分类号： C07D471/04

    CPC分类号： C07D215/48 ,  C07D401/06 ,  C07D401/12 ,  C07D405/06 ,  C07D405/12 ,  C07D413/04 ,  C07D471/04

    摘要： Compounds of formula I are effective modulators of JNK: wherein X is CR11 or N; Y is —C(O)R3, 5-membered heteroaryl, or 5-membered heterocyclyl; Z is phenyl, cycloalkyl, heterocyclyl or heteroaryl, and is substituted with R1 and R2; R1 and R2 are each independently H, halo, CN, lower alkyl, or —Y1—Y2—Y3—R8, or R1 and R2 together form —O(CH2)nO—, where n is 1 or 2; Y1 is —O—, —C(O)—, —C(O)O—, —C(O)NR9—, —NR9C(O)—, —S—, —SO2—, or a bond; Y2 is cycloalkylene, heterocycloalkylene, lower alkylene or a bond; Y3 is —O—, —C(O)—, —C(O)O—, —C(O)NR9—, —NR9C(O)—, —SO2—, or a bond; R8 is H, lower alkyl, lower alkoxy, cycloalkyl, heterocycloalkyl, or —NR9R10, wherein R8 other than H is optionally substituted with lower alkyl, halo, —CF3, or —OH; R9 and R10 are each independently H or lower alkyl; R3 is OH, lower alkyl, lower alkoxy, (lower alkoxy)-lower alkoxy, or —NR9R10; R4 is lower alkyl, phenyl, heterocyclyl, cycloalkyl, heterocycloalkyl, or heteroaryl, and is optionally substituted with lower alkyl, hydroxy, lower alkoxy, halo, nitro, amino, cyano, or halo-lower alkyl; R5 and R6 are each independently H, halo, cyano, lower alkyl, —CF3, lower alkoxy, —OCHF2, —NO2, or —NR9R10; R7 is H, F, Cl, methyl, or OH; R11 is H, lower alkyl, lower cycloalkyl, or phenyl; or a pharmaceutically acceptable salt thereof.

    摘要翻译： 式I化合物是JNK的有效调节剂：其中X是CR11或N; Y是-C（O）R 3，5元杂芳基或5元杂环基; Z是苯基，环烷基，杂环基或杂芳基，并被R1和R2取代; R1和R2各自独立地为H，卤素，CN，低级烷基或-Y1-Y2-Y3-R8，或R1和R2一起形成-O（CH 2）n O-，其中n为1或2; Y1是-O - ， - C（O） - ， - C（O）O - ， - C（O）NR 9 - ， - NR 9 C（O） - ， - S - ， - SO 2 - 或键; Y2是亚环烷基，杂环亚烷基，低级亚烷基或键; Y 3是-O - ， - C（O） - ， - C（O）O-，-C（O）NR 9 - ， - NR 9 C（O） - ， - SO 2 - 或键; R8是H，低级烷基，低级烷氧基，环烷基，杂环烷基或-NR9R10，其中R8以外的R8任选被低级烷基，卤素，-CF 3或-OH取代; R9和R10各自独立地为H或低级烷基; R3是OH，低级烷基，低级烷氧基，（低级烷氧基） - 低级烷氧基或-NR9R10; R 4是低级烷基，苯基，杂环基，环烷基，杂环烷基或杂芳基，并且任选被低级烷基，羟基，低级烷氧基，卤素，硝基，氨基，氰基或卤代低级烷基取代。 R 5和R 6各自独立地为H，卤素，氰基，低级烷基，-CF 3，低级烷氧基，-OCHF 2，-NO 2或-NR 9 R 10; R7是H，F，Cl，甲基或OH; R11是H，低级烷基，低级环烷基或苯基; 或其药学上可接受的盐。

    Heterocyclic antiviral compounds
    4.
    发明授权
    Heterocyclic antiviral compounds 失效
    杂环抗病毒化合物

    公开(公告)号：US08168792B2

    公开(公告)日：2012-05-01

    申请号：US12718207

    申请日：2010-03-05

    申请人： Sarah C. Abbot ,  Alfred Sui-Ting Lui ,  Jim Li ,  Francisco Xavier Talamas

    发明人： Sarah C. Abbot ,  Alfred Sui-Ting Lui ,  Jim Li ,  Francisco Xavier Talamas

    IPC分类号： C07D215/00

    CPC分类号： C07D401/04 ,  C07D405/04 ,  C07D491/048

    摘要： Compounds having the formula A-R wherein A is a heteroaryl and R is Ia, Ib or Ic and wherein A, R, R1, R2a, R2b, R2c, R3a, R3b, R4, R5, R6, Ra, Rb, Rc, Rd, X, X1, X2 and n are as are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.R is

    摘要翻译： 具有式AR的化合物，其中A是杂芳基，R是Ia，Ib或Ic，并且其中A，R，R1，R2a，R2b，R2c，R3a，R3b，R4，R5，R6，Ra，Rb，Rc，Rd， X，X1，X2和n如本文所定义的是丙型肝炎病毒NS5b聚合酶抑制剂。 还公开了用于治疗HCV感染和抑制HCV复制的组合物和方法。 R是